- Home
- ACXP vs USEA Comparison
ACXP vs USEA Comparison
Compare ACXP & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- USEA
- Stock Information
- Founded
- ACXP 2017
- USEA 2004
- Country
- ACXP United States
- USEA Greece
- Employees
- ACXP N/A
- USEA N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- ACXP Health Care
- USEA Consumer Discretionary
- Exchange
- ACXP Nasdaq
- USEA Nasdaq
- Market Cap
- ACXP 9.1M
- USEA 10.5M
- IPO Year
- ACXP 2021
- USEA N/A
- Fundamental
- Price
- ACXP $4.70
- USEA $1.58
- Analyst Decision
- ACXP Strong Buy
- USEA
- Analyst Count
- ACXP 3
- USEA 0
- Target Price
- ACXP $143.67
- USEA N/A
- AVG Volume (30 Days)
- ACXP 66.2K
- USEA 21.3K
- Earning Date
- ACXP 08-12-2025
- USEA 08-06-2025
- Dividend Yield
- ACXP N/A
- USEA 2.63%
- EPS Growth
- ACXP N/A
- USEA N/A
- EPS
- ACXP N/A
- USEA N/A
- Revenue
- ACXP N/A
- USEA $42,625,000.00
- Revenue This Year
- ACXP N/A
- USEA N/A
- Revenue Next Year
- ACXP N/A
- USEA $11.62
- P/E Ratio
- ACXP N/A
- USEA N/A
- Revenue Growth
- ACXP N/A
- USEA N/A
- 52 Week Low
- ACXP $3.80
- USEA $1.00
- 52 Week High
- ACXP $47.80
- USEA $2.78
- Technical
- Relative Strength Index (RSI)
- ACXP 33.75
- USEA 51.76
- Support Level
- ACXP $4.40
- USEA $1.50
- Resistance Level
- ACXP $5.29
- USEA $1.57
- Average True Range (ATR)
- ACXP 0.51
- USEA 0.07
- MACD
- ACXP 0.08
- USEA -0.01
- Stochastic Oscillator
- ACXP 40.91
- USEA 34.09
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.